Comprehensive Clinical Research LLC

1. Becton, Dickinson and Company $1,196,501 13 payments
2. Novavax Inc $289,333 46 payments
3. OraSure Technologies Inc. $98,444 5 payments
4. GlaxoSmithKline, LLC. $72,955 33 payments
5. Organon LLC $62,019 23 payments
6. Mylan Inc. $41,836 13 payments
7. Exeltis, USA Inc. $32,697 15 payments
8. Evofem Biosciences, Inc. $28,830 18 payments
9. Astellas Pharma Global Development $26,111 9 payments
10. BioNTech SE $9,500 1 payment

1. Veritor Antigen Assay $576,880 3 payments
2. CovSpec $403,387 4 payments
3. A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1 Adjuvant in Adult Participants older than or equal to 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years) $113,930 12 payments
4. InteliSwab COVID-19 Rapid Test Clinical Evaluation Study in Asymptomatic Individuals $98,444 5 payments
5. A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults older than 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2 $91,058 25 payments
6. QuickSilverFlu $84,866 2 payments
7. HPV Biospec $80,500 1 payment
8. A Phase 2/3 Open-Label Study to Evaluate the Safety and Immunogenicity of an XBB.1.5 (Omicron Subvariant) SARS CoV-2 rS Vaccine Booster Dose in Previously mRNA COVID 19 Vaccinated and Baseline SARS CoV 2 Seropositive COVID-19 Vaccine Naïve Participants $52,518 6 payments
9. Ids-Corngen04nrr $49,211 1 payment
10. Mr-100A-01-Td-3001-A Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $41,836 13 payments

1. Patient care $62,019 23 payments
2. Professional salary support $15,375 10 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.